Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
Cancer Genomics & Proteomics|June 29, 2026
NRF1 Activates the AMPK/SIRT1/PGC-1α/TFAM Axis to Suppress EMT and Tumor Progression in Lung AdenocarcinomaHsing-Hsien Wu, Pei-Fang Hsieh, Ming-DER Shi, et al.The Prostate|February 16, 2023
ATP8B1: A prognostic prostate cancer biomarker identified via genetic analysisLih-Chyang Chen, Shu-Pin Huang, Chieh-Tien Shih, et al.Journal of Clinical Medicine|November 26, 2022
Bladder Management Strategies for Urological Complications in Patients with Chronic Spinal Cord InjuryYu-Chen Chen, Yin-Chien Ou, Ju-Chuan Hu, et al.Cancer Cell International|May 6, 2022
TNFRSF13B is a potential contributor to prostate cancerChia-Yang Li, Shu-Pin Huang, Yei-Tsung Chen, et al.International Journal of Molecular Sciences|December 6, 2016
Prognostic Relevance of Methylenetetrahydrofolate Reductase Polymorphisms for Prostate CancerVictor C Lin, Te-Ling Lu, Hsin-Ling Yin, et al.Cancer Genomics & Proteomics|August 19, 2022
Nuclear Respiratory Factor 1 Overexpression Inhibits Proliferation and Migration of PC3 Prostate Cancer CellsChun-Hsien Wu, Pei-Fang Hsieh, Yen-Hsi Lee, et al.Cancer Cell International|April 19, 2019
Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progressionChia-Cheng Yu, Lih-Chyang Chen, Chih-Yung Chiou, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|May 11, 2010
Individual and cumulative association of prostate cancer susceptibility variants with clinicopathologic characteristics of the diseaseBo-Ying Bao, Jiunn-Bey Pao, Victor C Lin, et al.Annals of Surgical Oncology|March 6, 2010
Clinical significance of tumor necrosis factor receptor superfamily member 11b polymorphism in prostate cancerBo-Ying Bao, Victor C Lin, Shu-Hung Huang, et al.Oncotarget|November 2, 2017
Vitamin D receptor-binding site variants affect prostate cancer progressionVictor C Lin, Shu-Pin Huang, Huei-Ju Ting, et al.Pageof 6